Advertisement

Interstitial Lung Abnormality—Why Should I Care and What Should I Do About It?

Published:September 02, 2022DOI:https://doi.org/10.1016/j.rcl.2022.06.002

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Radiologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hatabu H.
        • Hunninghake G.M.
        • Richeldi L.
        • et al.
        Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.
        Lancet Respir Med. 2020; 8: 726-737
        • Putman R.K.
        • Hatabu H.
        • Araki T.
        • et al.
        Association Between Interstitial Lung Abnormalities and All-Cause Mortality.
        JAMA. 2016; 315: 672-681
        • Hoyer N.
        • Wille M.M.W.
        • Thomsen L.H.
        • et al.
        Interstitial lung abnormalities are associated with increased mortality in smokers.
        Respir Med. 2018; 136: 77-82
        • Lee T.S.
        • Jin K.N.
        • Lee H.W.
        • et al.
        Interstitial Lung Abnormalities and the Clinical Course in Patients With COPD.
        Chest. 2021; 159: 128-137
        • Araki T.
        • Putman R.K.
        • Hatabu H.
        • et al.
        Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study.
        Am J Respir Crit Care Med. 2016; 194: 1514-1522
        • Nakanishi Y.
        • Masuda T.
        • Yamaguchi K.
        • et al.
        Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
        Respir Investig. 2019; 57: 451-459
        • Li F.
        • Zhou Z.
        • Wu A.
        • et al.
        Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
        Radiat Oncol. 2018; 13: 1-9
        • Shimoji K.
        • Masuda T.
        • Yamaguchi K.
        • et al.
        Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers.
        JAMA Netw Open. 2020; 3: e2022906
        • Hunninghake G.M.
        • Hatabu H.
        • Okajima Y.
        • et al.
        MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities.
        N Engl J Med. 2013; 368: 2192-2200
        • Jin G.Y.
        • Lynch D.
        • Chawla A.
        • et al.
        Interstitial Lung Abnormalities in a CT Lung Cancer Screening Population: Prevalence and Progression Rate.
        Radiology. 2013; 268: 563-571
        • Buendía-Roldán I.
        • Fernandez R.
        • Mejía M.
        • et al.
        Risk factors associated with the development of interstitial lung abnormalities.
        Eur Respir J. 2021; 58https://doi.org/10.1183/13993003.03005-2020
      1. Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2013;364(10):897–906.

        • Sanders J.L.
        • Putman R.K.
        • Dupuis J.
        • et al.
        The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality.
        Am J Respir Crit Care Med. 2021; 203: 1149-1157
        • Sverzellati N.
        • Guerci L.
        • Randi G.
        • et al.
        Interstitial lung diseases in a lung cancer screening trial.
        Eur Respir J. 2011; 38: 392-400
        • Whittaker Brown S.A.
        • Padilla M.
        • Mhango G.
        • et al.
        Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial.
        Chest. 2019; 156: 1195-1203
        • Sack C.
        • Vedal S.
        • Sheppard L.
        • et al.
        Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air–lung study.
        Eur Respir J. 2017; 50https://doi.org/10.1183/13993003.00559-2017
        • Sack C.S.
        • Doney B.C.
        • Podolanczuk A.J.
        • et al.
        Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies.
        Am J Respir Crit Care Med. 2017; 196: 1031-1039
        • Mathai S.K.
        • Humphries S.M.
        • Kropski J.A.
        • et al.
        MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis.
        Thorax. 2019; 74: 1131-1139
      2. Seibold MA, Wise AL, Speer MC, et al. A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis. https://doi.org.proxy.hsl.ucdenver.edu/10.1056/NEJMoa1013660.

        • Putman R.K.
        • Gudmundsson G.
        • Araki T.
        • et al.
        The MUC5B Promoter Polymorphism Is Associated with Specific Interstitial Lung Abnormality Subtypes.
        Eur Respir J. 2017; 50: 1700537
        • Hobbs B.D.
        • Putman R.K.
        • Araki T.
        • et al.
        Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.
        Am J Respir Crit Care Med. 2019; 200: 1402-1413
        • Putman R.K.
        • Gudmundsson G.
        • Axelsson G.T.
        • et al.
        Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.
        Am J Respir Crit Care Med. 2019; 200: 175-183
        • Kadoch M.
        • Kitich A.
        • Alqalyoobi S.
        • et al.
        Interstitial Lung Abnormality is Prevalent and Associated with Worse Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement.
        Respir Med. 2018; 137: 55-60
        • Hino T.
        • Hida T.
        • Nishino M.
        • et al.
        Progression of traction bronchiectasis/bronchiolectasis in interstitial lung abnormalities is associated with increased all-cause mortality: Age Gene/Environment Susceptibility-Reykjavik Study.
        Eur J Radiol Open. 2021; 8: 100334
        • Hida T.
        • Hata A.
        • Lu J.
        • et al.
        Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study.
        Cancer Imaging. 2021; 21: 14
        • Araki T.
        • Dahlberg S.E.
        • Hida T.
        • et al.
        Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.
        Eur J Radiol Open. 2019; 6: 128-131
        • Nishino M.
        • Cardarella S.
        • Dahlberg S.E.
        • et al.
        Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.
        Eur J Radiol. 2015; 84: 998-1004
        • Axelsson G.T.
        • Putman R.K.
        • Aspelund T.
        • et al.
        The Associations of Interstitial Lung Abnormalities with Cancer Diagnoses and Mortality.
        Eur Respir J. 2020; 56: 1902154
        • Rice M.B.
        • Li W.
        • Schwartz J.
        • et al.
        Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study.
        Thorax. 2019; 74: 1063-1069
        • Synn A.J.
        • Li W.
        • Hunninghake G.M.
        • et al.
        Vascular Pruning on Computed Tomography and Interstitial Lung Abnormalities in the Framingham Heart Study.
        CHEST. 2020; 0https://doi.org/10.1016/j.chest.2020.07.082
        • Chae K.J.
        • Chung M.J.
        • Jin G.Y.
        • et al.
        Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival.
        Eur Radiol. 2022; https://doi.org/10.1007/s00330-021-08378-8
        • Hoyer N.
        • Thomsen L.H.
        • Wille M.M.W.
        • et al.
        Increased respiratory morbidity in individuals with interstitial lung abnormalities.
        BMC Pulm Med. 2020; 20: 67https://doi.org/10.1186/s12890-020-1107-0
        • Im Y.
        • Park H.Y.
        • Shin S.
        • et al.
        Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer.
        Respir Res. 2019; 20: 1-9
        • Kobayashi H.
        • Wakuda K.
        • Naito T.
        • et al.
        Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
        Radiat Oncol. 2021; 16: 1-9
        • Lynch D.A.
        • Sverzellati N.
        • Travis W.D.
        • et al.
        Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
        Lancet Respir Med. 2018; 6: 138-153
        • Hansell D.M.
        Thin-Section CT of the Lungs: The Hinterland of Normal.
        Radiology. 2010; 256: 695-711
        • Hata A.
        • Schiebler M.L.
        • Lynch D.A.
        • et al.
        Interstitial Lung Abnormalities: State of the Art.
        Radiology. 2021; 301: 19-34
        • Raghu G.
        • Remy-Jardin M.
        • Myers J.L.
        • et al.
        Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
        Am J Respir Crit Care Med. 2018; 198: e44-e68
        • Otani H.
        • Tanaka T.
        • Murata K.
        • et al.
        Smoking-related interstitial fibrosis combined with pulmonary emphysema: computed tomography-pathologic correlative study using lobectomy specimens.
        Int J Chron Obstruct Pulmon Dis. 2016; 11: 1521-1532https://doi.org/10.2147/COPD.S107938
        • Watanabe Y.
        • Kawabata Y.
        • Kanauchi T.
        • et al.
        Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis.
        Eur J Radiol. 2015; 84: 986-992
        • Uppaluri R.
        • Hoffman E.A.
        • Sonka M.
        • et al.
        Interstitial Lung Disease.
        Am J Respir Crit Care Med. 1999; 159: 519-525
        • Bartholmai B.J.
        • Raghunath S.
        • Karwoski R.A.
        • et al.
        Quantitative CT Imaging of Interstitial Lung Diseases.
        J Thorac Imaging. 2013; 28 (1097/RTI.0b013e3182a21969): 10
        • Ash S.Y.
        • Harmouche R.
        • Ross J.C.
        • et al.
        The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers.
        Acad Radiol. 2017; 24: 941-946
        • Humphries S.M.
        • Yagihashi K.
        • Huckleberry J.
        • et al.
        Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up.
        Radiology. 2017; 285: 270-278
        • Christodoulidis S.
        • Anthimopoulos M.
        • Ebner L.
        • et al.
        Multisource Transfer Learning With Convolutional Neural Networks for Lung Pattern Analysis.
        IEEE J Biomed Health Inform. 2017; 21: 76-84
        • Wu X.
        • Kim G.H.
        • Salisbury M.L.
        • et al.
        Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.
        Am J Respir Crit Care Med. 2018; 199: 12-21
        • Ash S.Y.
        • Harmouche R.
        • Putman R.K.
        • et al.
        Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.
        Chest. 2017; 152: 780-791
        • Matson S.M.
        • Deane K.D.
        • Peljto A.L.
        • et al.
        Prospective Identification of Subclinical Interstitial Lung Disease in Rheumatoid Arthritis Cohort is Associated with the MUC5B Promoter Variant.
        Am J Respir Crit Care Med. 2021; (rccm.202109–2087LE)
        • Hunninghake G.M.
        • Goldin J.G.
        • Kadoch M.A.
        • et al.
        Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
        Chest. 2021; https://doi.org/10.1016/j.chest.2021.06.035
        • Podolanczuk A.J.
        • Putman R.K.
        Clinical Relevance and Management of “Pre–Interstitial Lung Disease.”.
        Clin Chest Med. 2021; 42: 241-249